Thomas O. Schrader
Arena Pharmaceuticals (United States)(US)General Atomics (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Organophosphorus compounds synthesis, Synthesis and Reactivity of Sulfur-Containing Compounds, Neuropeptides and Animal Physiology, Sphingolipid Metabolism and Signaling
Most-Cited Works
- → Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure(1999)190 cited
- → 3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice(2008)93 cited
- → (PCy3)2Cl2RuCHPh Catalyzed Kharasch additions. Application in a formal olefin carbonylation(2004)58 cited
- → Stereodivergent Synthesis of All 15-F2 Isoprostanes(2002)54 cited
- → (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans(2012)51 cited
- → Complementary Asymmetric Routes to (R)-2-(7-Hydroxy-2,3-dihydro-1H-pyrrolo[1,2-]indol-1-yl)acetate